John Kotter — University of Kentucky

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Residency, Univ Of Kentucky

2012

Doctor of Medicine, Univ Of Utah

2009

Bachelor of Science, Univ Of Utah

2004

5 Finished
5 Active

Victorian-2 Prevent: A Randomized Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing The Impact of Inclisiran On Major Adverse Cardiovascular Events In Participants With Established Cardiovascular Disease
Kotter, J.
Novartis (domestic)
10/27/22 → 9/13/23
Project: Research project
EMPACT-MI: EMPAgliflozin for the Prevention of Chronic Heart Failure and MorTality After an Acute Myocardial Infarction.
Kotter, J.
Boehringer Ingelheim Pharmaceuticals Incorporated (US)
4/21/21 → 11/27/23
Project: Research project
PB2452 Phase 3 Ticagrelor Reversal Study (PB2452-PT-CL-0004
Kotter, J. & Abdel-Latif, A.
PhaseBio Pharmaceuticals Incorporated
1/7/21 → 8/21/23
Project: Research project
SPYRAL HTN OFF Meds
Kotter, J. & Ziada, K.
Medtronics Inc
6/22/15 → 7/7/24
Project: Research project
SPYRAL HTN ON MEDS
Kotter, J. & Ziada, K.
Medtronics Inc
6/22/15 → 7/7/24
Project: Research project

Fellow of the American Society of Echocardiography (FASE)
Kotter, John (Recipient), 2021
Prize: Honorary award